default author photo

Andres E. Fraceschi

affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

74

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

An Open-Label Phase Ii Trial of Sotrovimab (Vir-7831) Prophylaxis Against Covid-19 Infection in Immunocompromised Individuals with Impaired Sars-Cov-2 Humoral Immunity

Number of pages: 33 Posted: 21 Mar 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Tufts University - Tufts Medical Center, affiliation not provided to SSRN, Staten Island University Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, GlaxoSmithKline, affiliation not provided to SSRN, GlaxoSmithKline - Pennsylvania, affiliation not provided to SSRN, Harvard University, affiliation not provided to SSRN, affiliation not provided to SSRN, Harvard University - Brigham and Women's Hospital and affiliation not provided to SSRN
Downloads 74 (844,901)

Abstract:

Loading...

immunocompromised host, COVID-19, pre-exposure prophylaxis, monoclonal antibodies